Cover Page The handle http://hdl.handle.net/1887/45998

Chapter 7 The Impact Of Polymorphisms In The Deiodinase 1 (D1) And Deiodinase 2 (D2) Gene On Mood And Well-Being In Patients Treated For Differentiated Thyroid Carcinoma

Furthermore, during long-term follow-up thyroid hormone serum levels are frequently measured and the majority of patients have a normal life-span related to high cure rates.. Mostly,

As neither BMP7 nor its R-Smads differential expression have been studied in thyroid; we set out to study the expression of BMP7, Smad4 and phospho-Smad1 (pSmad1),

Supplemental Table 2Risk of bias in included studies Studies Inclusion of consecutive patients Loss to follow-up Inclusion of euthyroid patients only Preoperative thyroid hormone use

Because an increased need of thyroxine is observed in athyreotic patients who are treated with tyrosine kinase inhibitors, the mechanisms of hypothyroidism may include alterations

In a study of athy- reotic patients on TSH suppression therapy for advanced thyroid carcinoma, TSH concentrations after recombinant human TSH (rhTSH) injections were measured

Supplementary table 1 General overview of studies and their primary clinical endpoints Study Deiodinase polymorphismNumber ofpatientsClinical EndpointClinical outcome Mentuccia

(4, 16) The present project endeavoured to study whether there is a relationship between common polymorphisms in D1 ((D1-C785T and D1-A1814G) and D2 (D2-Thr92Ala and